Jasmin Jo

450 total citations
19 papers, 298 citations indexed

About

Jasmin Jo is a scholar working on Genetics, Pulmonary and Respiratory Medicine and Neurology. According to data from OpenAlex, Jasmin Jo has authored 19 papers receiving a total of 298 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Genetics, 7 papers in Pulmonary and Respiratory Medicine and 5 papers in Neurology. Recurrent topics in Jasmin Jo's work include Glioma Diagnosis and Treatment (14 papers), Brain Metastases and Treatment (6 papers) and Venous Thromboembolism Diagnosis and Management (5 papers). Jasmin Jo is often cited by papers focused on Glioma Diagnosis and Treatment (14 papers), Brain Metastases and Treatment (6 papers) and Venous Thromboembolism Diagnosis and Management (5 papers). Jasmin Jo collaborates with scholars based in United States, Netherlands and Canada. Jasmin Jo's co-authors include David Schiff, James Perry, Mark E. Smolkin, Patrick Y. Wen, Benjamin Purow, Maria Beatriz Lopes, Camilo E. Fadul, Sarah J. Ratcliffe, Loren D. Erickson and Samuel Young and has published in prestigious journals such as Neurology, American Journal of Clinical Pathology and Cells.

In The Last Decade

Jasmin Jo

18 papers receiving 294 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jasmin Jo United States	11	137	86	67	61	51	19	298
Anne Berberich Germany	12	129 0.9×	42 0.5×	131 2.0×	134 2.2×	73 1.4×	16	365
Marc‐Alexander Brockmann Germany	12	46 0.3×	65 0.8×	138 2.1×	173 2.8×	111 2.2×	18	374
Vincent J. Cheung United States	6	142 1.0×	13 0.2×	210 3.1×	71 1.2×	34 0.7×	14	402
Yuhei Sangatsuda Japan	14	320 2.3×	12 0.1×	84 1.3×	68 1.1×	103 2.0×	48	463
Bhuvic Patel United States	12	109 0.8×	6 0.1×	84 1.3×	67 1.1×	78 1.5×	20	413
Chiara Bosa Italy	9	126 0.9×	7 0.1×	44 0.7×	29 0.5×	60 1.2×	16	241
Vincent Cheung United States	7	343 2.5×	16 0.2×	131 2.0×	127 2.1×	101 2.0×	13	510
Steve Pakola Belgium	11	19 0.1×	27 0.3×	52 0.8×	73 1.2×	145 2.8×	20	528
Yutaka Fujioka Japan	11	193 1.4×	5 0.1×	61 0.9×	44 0.7×	70 1.4×	48	321
Clemens Seidel Germany	12	412 3.0×	11 0.1×	201 3.0×	137 2.2×	115 2.3×	60	559

Countries citing papers authored by Jasmin Jo

Since Specialization

Citations

This map shows the geographic impact of Jasmin Jo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jasmin Jo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jasmin Jo more than expected).

Fields of papers citing papers by Jasmin Jo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jasmin Jo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jasmin Jo. The network helps show where Jasmin Jo may publish in the future.

Co-authorship network of co-authors of Jasmin Jo

This figure shows the co-authorship network connecting the top 25 collaborators of Jasmin Jo. A scholar is included among the top collaborators of Jasmin Jo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jasmin Jo. Jasmin Jo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Jo, Jasmin, James T. Patrie, David Joyner, et al.. (2025). Presenting clinical and radiographic features of diffuse glioma molecular subtypes in accordance with the 2021 CNS5 WHO classification. Neuro-Oncology Practice. 12(6). 1030–1039.

Farooq, Sarah, et al.. (2024). Bihemispheric IDH-Wildtype Glioblastoma with Unilateral FGFR3-TACC3 Fusion in Patient with Breast Cancer History: A Case Report and Literature Review. American Journal of Clinical Pathology. 162(Supplement_1). S133–S134. 1 indexed citations

Jo, Jasmin, et al.. (2023). First application of GammaTile cesium-131 brachytherapy with maximal safe resection of a glioma in a patient with limited scleroderma. Journal of Contemporary Brachytherapy. 15(5). 365–371. 2 indexed citations

Jo, Jasmin, Craig Horbinski, Nigel Mackman, et al.. (2023). Epidemiology, biology, and management of venous thromboembolism in gliomas: An interdisciplinary review. Neuro-Oncology. 25(8). 1381–1394. 17 indexed citations

Asthagiri, Ashok R., et al.. (2023). Fatal Intracranial Hemorrhage With Belzutifan in von Hippel-Lindau Disease–Associated Hemangioblastoma: A Case Report. JCO Precision Oncology. 7(7). e2300066–e2300066. 6 indexed citations

Jo, Jasmin & David Schiff. (2022). Current Considerations in the Treatment of Grade 3 Gliomas. Current Treatment Options in Oncology. 23(9). 1219–1232. 3 indexed citations

Jo, Jasmin, et al.. (2022). Venous Thrombotic Events and Anticoagulation in Brain Tumor Patients. Current Oncology Reports. 24(4). 493–500. 10 indexed citations

Jo, Jasmin, Martin J. van den Bent, Burt Nabors, Patrick Y. Wen, & David Schiff. (2022). Surveillance imaging frequency in adult patients with lower-grade (WHO Grade 2 and 3) gliomas. Neuro-Oncology. 24(7). 1035–1047. 15 indexed citations

Winter, Sebastian, Jasmin Jo, David Schiff, & Jörg Dietrich. (2021). Central Nervous System Complications Among Oncology Patients. Hematology/Oncology Clinics of North America. 36(1). 217–236. 6 indexed citations

10.

Mauldin, Ileana S., Jasmin Jo, Nolan A. Wages, et al.. (2021). Proliferating CD8+ T Cell Infiltrates Are Associated with Improved Survival in Glioblastoma. Cells. 10(12). 3378–3378. 49 indexed citations

11.

Jo, Jasmin, et al.. (2021). Management of venous thromboembolism in high-grade glioma: Does low molecular weight heparin increase intracranial bleeding risk?. Neuro-Oncology. 24(3). 455–464. 15 indexed citations

12.

Jo, Jasmin, et al.. (2020). Predictors of early, recurrent, and intractable seizures in low-grade glioma. Neuro-Oncology Practice. 8(1). 40–47. 19 indexed citations

13.

Jo, Jasmin, et al.. (2020). Risk of Venous Thromboembolism in Grade II–IV Gliomas as a Function of Molecular Subtype. Neurology. 96(7). e1063–e1069. 27 indexed citations

14.

Jo, Jasmin, et al.. (2019). P14.23 Risk of venous thromboembolism (VTE) in grade II-IV gliomas as a function of molecular subtype. Neuro-Oncology. 21(Supplement_3). iii71–iii72. 1 indexed citations

15.

Jo, Jasmin & Patrick Y. Wen. (2018). Antiangiogenic Therapy of High-Grade Gliomas. Progress in neurological surgery. 31. 180–199. 11 indexed citations

16.

Jo, Jasmin & David Schiff. (2017). Management of neuro-oncologic emergencies. Handbook of clinical neurology. 141. 715–741. 12 indexed citations

17.

Jo, Jasmin, Brian J. Williams, Mark E. Smolkin, et al.. (2014). Effect of neoadjuvant temozolomide upon volume reduction and resection of diffuse low-grade glioma. Journal of Neuro-Oncology. 120(1). 155–161. 13 indexed citations

18.

Jo, Jasmin, David Schiff, & James Perry. (2014). Thrombosis in Brain Tumors. Seminars in Thrombosis and Hemostasis. 40(3). 325–331. 66 indexed citations

19.

Jo, Jasmin, David Schiff, & Benjamin Purow. (2012). Angiogenic inhibition in high-grade gliomas: past, present and future. Expert Review of Neurotherapeutics. 12(6). 733–747. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact